Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cell DNA methylation refers to the aberrant methylation patterns observed in the DNA of cancer cells, characterized by hypermethylation of tumor suppressor genes and global hypomethylation. These epigenetic modifications play a crucial role in regulating gene expression and contribute to oncogenesis. Detection of these aberrant methylation patterns serves as a valuable biomarker for cancer diagnostics and monitoring, and targeting DNA methylation is an area of active therapeutic investigation.
DNA methylation inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell DNA (via methylation).